Position in ABT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$800,076,351
-$211,593,059 QoQ
Shares Held
8,817,240
-10.5% QoQ
Ownership
0.506%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#31
of 2,948 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 96%
None 4%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Derivatives in ABT
reported options exposure · as of Dec 31, 2020CallValue
$394,164
CallShares
3,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Medical Devices
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $8,138,900,714 across 73 Medical Devices names. ABT ranks #4 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
17,885,150 | $1,399,155,274 | |
| 2 | GEHC |
GE HealthCare Technologies Inc.
|
18,296,350 | $1,171,149,358 | |
| 3 | DXCM |
Dexcom Inc
|
15,288,133 | $1,029,655,749 | |
| 4 | ABT |
Abbott Laboratories
This page
|
8,817,240 | $800,076,351 | |
| 5 | BSX |
Boston Scientific Corp
|
13,800,748 | $589,015,917 | |
| 6 | SYK |
Stryker Corp
|
1,855,162 | $584,079,197 | |
| 7 | STE |
STERIS plc
|
1,806,187 | $380,328,785 | |
| 8 | EW |
Edwards Lifesciences Corp
|
3,977,518 | $359,806,272 |
All Filings in ABT
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $800,076,351 | 8,817,240 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,011,669,410 | 9,853,603 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $1,671,492,750 | 13,340,991 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $1,868,718,410 | 13,951,907 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,256,565,366 | 9,238,772 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,106,757,173 | 8,343,439 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,020,074,493 | 9,018,429 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $806,062,089 | 7,070,100 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $559,287,666 | 5,382,424 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $689,082,949 | 6,062,669 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $659,357,923 | 5,990,351 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $576,228,435 | 5,949,700 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $646,363,109 | 5,928,849 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $625,796,004 | 6,180,091 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $638,390,084 | 5,814,647 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $561,721,397 | 5,805,306 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $539,984,297 | 4,969,943 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $598,535,857 | 5,056,910 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $804,467,436 | 5,715,983 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $623,266,629 | 5,276,108 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $688,512,435 | 5,939,036 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $730,733,501 | 6,097,576 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $394,164 | 3,600 | Call | Defined | 2021-02-16 | |
| 2020-12-31 | $600,304,758 | 5,482,736 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $618,071,141 | 5,679,235 | Shares | Sole | 2020-11-16 | |
| 2020-09-30 | $489,735 | 4,500 | Call | Defined | 2020-11-16 | |
| 2020-06-30 | $420,578 | 4,600 | Call | Defined | 2020-08-14 | |
| 2020-06-30 | $518,759,916 | 5,673,848 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $501,008,263 | 6,349,110 | Shares | Sole | 2020-05-15 | |
| 2020-03-31 | $362,986 | 4,600 | Call | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||